Amarillo Biosciences, Inc. announced that Steven T Chen assumed the duties and title of Chief Financial Officer of the Company (CFO) effective February 3, 2019, in addition to his present duties and titles of President, CEO, and Chairman of the Board; and, Bernard Cohen, heretofore Vice President and CFO, relinquished the duties and title of CFO, and assumed the duties and title of Vice-President- Administration effective February 3, 2019.